Arrhythmias & electrophysiology

Combined pulsed field ablation of atrial fibrillation and left atrial appendage occlusion: A single-center experience

Heart RhythmPublished Retrospective cohort study

Authors' conclusion

Combined PFA and LAAO was feasible with high implant success, low periprocedural complication rates, and favorable outcomes through 1 year.

Study context

Population
Patients with atrial fibrillation (AF) undergoing combined pulsed field ablation (PFA) and left atrial appendage occlusion (LAAO) (Watchman FLX Pro) in a single procedure, March–October 2024all had 1-year follow-up
Participants
45 patients
Outcome
Procedural feasibility, safety and outcomes of combined PFA and LAAO
Follow-up
1 year
Methodological detailssingle-centre, consecutive patients
  • Single-centre
  • Consecutive patients

Main finding

As reported in the abstract

Implant success

44 patients

98%

Median procedural time (IQR 80-107 minutes)

90 minutes

Median fluoroscopy time (IQR 18-30 minutes)

24 minutes

Observational data: associations, not effects.

Further findings

Complete seal (0 mm peridevice leak) · 45 days

Complete seal
41 patients (93%)
  • n = 44

Imaging at 1 year

Imaging performed
20 (44.45)
Complete seal
18 (90%)
Minor peridevice leak (≤3 mm)
2 (10%)
No device-related thrombus or device embolization

Safety

Periprocedural complications

Pericarditis
1 patient
Deaths, strokes, major bleeding, pericardial effusions requiring intervention
0

Events during follow-up · 1 year

Pericardial effusion requiring intervention
1
Major gastrointestinal bleeding
1

Device-related thrombus · 45 days

Device-related thrombus, resolved with DOAC and absent at 1 year
1

Original publication

Combined pulsed field ablation of atrial fibrillation and left atrial appendage occlusion: A single-center experience. Heart Rhythm. Published 16 December 2025. doi:10.1016/j.hrthm.2025.12.017

Summarised from the published abstract; every number is checked against it

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.